BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 18307017)

  • 1. Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update.
    Ishihara K; Saida T; Otsuka F; Yamazaki N;
    Int J Clin Oncol; 2008 Feb; 13(1):33-41. PubMed ID: 18307017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updated statistical data for malignant melanoma in Japan.
    Ishihara K; Saida T; Yamamoto A;
    Int J Clin Oncol; 2001 Jun; 6(3):109-16. PubMed ID: 11706778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and prognosis of plantar melanoma in 62 Japanese patients over a 28-year period.
    Kato T; Suetake T; Tabata N; Takahashi K; Tagami H
    Int J Dermatol; 1999 Jul; 38(7):515-9. PubMed ID: 10440280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical survey from 1982 to 1991 of 49 patients with malignant melanocytic tumors.
    Ueda E; Kishimoto S; Yasuno H
    J Dermatol; 1995 Jul; 22(7):467-74. PubMed ID: 7560435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Survival analysis in patients with cutaneous malignant melanoma].
    Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
    Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience.
    Seegenschmiedt MH; Keilholz L; Altendorf-Hofmann A; Urban A; Schell H; Hohenberger W; Sauer R
    Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):607-18. PubMed ID: 10348291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acral Lentiginous Melanoma: Incidence and Survival in the United States, 2006-2015, an Analysis of the SEER Registry.
    Huang K; Fan J; Misra S
    J Surg Res; 2020 Jul; 251():329-339. PubMed ID: 32208196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant melanoma in Taiwan: a prognostic study of 181 cases.
    Chang JW; Yeh KY; Wang CH; Yang TS; Chiang HF; Wei FC; Kuo TT; Yang CH
    Melanoma Res; 2004 Dec; 14(6):537-41. PubMed ID: 15577327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Get Data Out' Skin: national cancer registry incidence and survival rates for all registered skin tumour groups for 2013-2019 in England.
    van Bodegraven B; Vernon S; Eversfield C; Board R; Craig P; Gran S; Harwood CA; Keohane S; Levell NJ; Matin RN; Proby C; Rajan N; Rous B; Ascott A; Millington GWM; Venables ZC;
    Br J Dermatol; 2023 May; 188(6):777-784. PubMed ID: 36814132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and pathological features of cutaneous malignant melanoma: a retrospective analysis of 124 Japanese patients.
    Kuno Y; Ishihara K; Yamazaki N; Mukai K
    Jpn J Clin Oncol; 1996 Jun; 26(3):144-51. PubMed ID: 8656554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nodular melanoma in 62 Japanese patients: influence of initial surgical treatment on local recurrence and prognosis.
    Kato T; Suetake T; Kumasaka N; Tabata N; Sugiyama Y; Tagami H
    J Dermatol; 1995 Oct; 22(10):723-8. PubMed ID: 8586749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acral lentiginous melanoma versus other melanoma: A single-center analysis in Japan.
    Wada M; Ito T; Tsuji G; Nakahara T; Hagihara A; Furue M; Uchi H
    J Dermatol; 2017 Aug; 44(8):932-938. PubMed ID: 28342269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society.
    Garbe C; Orfanos CE
    Pigment Cell Res; 1992; Suppl 2():285-94. PubMed ID: 1409431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of second-stage screening for skin cancers in Oita Prefecture, Japan.
    Kai Y; Ishikawa K; Goto M; Sakai T; Ito A; Shono T; Shimada H; Shimizu F; Goto M; Hatano Y; Okamoto O; Katagiri K; Aono H; Eshima N; Fujiwara S
    J Dermatol; 2015 Dec; 42(12):1160-4. PubMed ID: 26177589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanoma.
    Fujisawa Y; Yoshikawa S; Minagawa A; Takenouchi T; Yokota K; Uchi H; Noma N; Nakamura Y; Asai J; Kato J; Fujiwara S; Fukushima S; Uehara J; Hoashi T; Kaji T; Fujimura T; Namikawa K; Yoshioka M; Murao N; Ogata D; Matsuyama K; Hatta N; Shibayama Y; Fujiyama T; Ishikawa M; Yamada D; Kishi A; Nakamura Y; Shimiauchi T; Fujii K; Fujimoto M; Ihn H; Katoh N
    Cancer Med; 2019 May; 8(5):2146-2156. PubMed ID: 30932370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and survival rates of primary cutaneous malignancies in Korea, 1999-2019: A nationwide population-based study.
    Kwon SH; Choi S; Kim JS; Kim SS; Jue MS; Seo SH; Park J; Roh MR; Mun JH; Kim JY; Choi JW; Byun JW; Park S; Kim MS; Lee SJ;
    J Dermatol; 2024 Apr; 51(4):532-538. PubMed ID: 38366757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long term results following radiation therapy of locally recurrent and metastatic malignant melanoma].
    Seegenschmiedt MH; Keilholz L; Altendorf-Hofmann A; Pieritz A; Urban A; Schell H; Hohenberger W; Sauer R
    Hautarzt; 1999 Aug; 50(8):572-9. PubMed ID: 10460301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases.
    Chi Z; Li S; Sheng X; Si L; Cui C; Han M; Guo J
    BMC Cancer; 2011 Feb; 11():85. PubMed ID: 21349197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does chemosensitivity-assay-directed therapy have an influence on the prognosis of patients with malignant melanoma stage IV? A retrospective study of 14 patients with malignant melanoma stage IV.
    Doerler M; Hyun J; Venten I; Potthoff A; Bartke U; Serova K; Hoextermann S; Altmeyer P; Brockmeyer NH
    Eur J Med Res; 2007 Oct; 12(10):497-502. PubMed ID: 18024256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.